Considering that high expression of SKA3 was negatively correlated with “early estrogen response” in the GSEA, it strongly further suggested that SKA3 overexpression might contribute to tumor progression by inhibiting estrogen response early in BC. The gene discussed is SKA3; the disease is breast cancer.